BlackRock’s Biote Corp BTMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.35M Sell
1,739,244
-29,732
-2% -$59.8K ﹤0.01% 4088
2025
Q4
$4.6M Buy
1,768,976
+26,200
+2% +$71.6K ﹤0.01% 3868
2025
Q3
$5.23M Sell
1,742,776
-17,130
-1% -$61.2K ﹤0.01% 3766
2025
Q2
$7.07M Buy
1,759,906
+34,372
+2% +$127K ﹤0.01% 3583
2025
Q1
$5.75M Sell
1,725,534
-8,003
-0.5% -$38.2K ﹤0.01% 3594
2024
Q4
$10.7M Buy
1,733,537
+7,662
+0.4% +$44.5K ﹤0.01% 3389
2024
Q3
$9.63M Buy
1,725,875
+120,847
+8% +$806K ﹤0.01% 3428
2024
Q2
$12M Buy
1,605,028
+632,194
+65% +$3.9M ﹤0.01% 3276
2024
Q1
$5.64M Buy
972,834
+237
+0% +$1.19K ﹤0.01% 3620
2023
Q4
$4.8M Buy
972,597
+237,650
+32% +$1.22M ﹤0.01% 3708
2023
Q3
$3.76M Buy
734,947
+138,866
+23% +$818K ﹤0.01% 3779
2023
Q2
$4.03M Buy
+596,081
New +$3.54M ﹤0.01% 3800

Other funds holding BTMD

BlackRock's BTMD Position: Q1 2026 in Review

BlackRock reduced its Biote Corp (BTMD) stake by 1.7% in Q1 2026, selling an estimated $59.8K and leaving 1,739,244 shares worth $2.35M. The position accounts for ﹤0.01% of the portfolio, ranked #4088.

BlackRock first reported a position in BTMD in Q2 2023 and has held it in 12 quarters since. The position peaked at $12M in Q2 2024. 84 funds tracked by Wall St. Rank hold BTMD as of Q1 2026.

  • BlackRock held 1,739,244 shares of Biote Corp worth $2.35M as of Q1 2026.
  • BlackRock sold 29,732 Biote Corp shares in Q1 2026, an estimated $59.8K.
  • Biote Corp made up ﹤0.01% of BlackRock's portfolio in Q1 2026, its #4088 holding.
  • BlackRock first reported a position in Biote Corp in Q2 2023 and has held it in 12 quarters since.
  • BlackRock's Biote Corp position peaked at $12M in Q2 2024.
  • 84 funds tracked by Wall St. Rank held Biote Corp as of Q1 2026.

Based on BlackRock's 13F filing for Q1 2026, filed 13 May 2026.